(90 days)
No
The description focuses on receiving, processing, and transmitting alarm information from existing patient monitors. It explicitly states the device "does not acquire physiological signals from a patient nor does it process the physiological data received from the patient monitors to determine patient status." There is no mention of AI, ML, or any learning or adaptive algorithms.
No.
The device's intended use and description clearly state it is for secondary annunciation and display of alarm conditions, not for treating or diagnosing medical conditions. It transmits information generated by other patient monitoring systems and does not interact directly with the patient for therapeutic purposes.
No
The device is described as a system for secondary annunciation and display of alarm conditions from patient monitors to caregivers. It explicitly states, "The IMPACT.wf Server does not acquire physiological signals from a patient nor does it process the physiological data received from the patient monitors to determine patient status. These functions are reserved for the patient monitoring system." This indicates it is not involved in diagnosing patient conditions, but rather in relaying information already processed by primary monitoring systems.
No
The device description explicitly lists hardware components such as a Server (PC platform), Micro Serial Server, Transmitter, and Receiver(s) (Pagers), and mentions hardware testing in the performance studies summary.
Based on the provided information, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- IVD definition: In Vitro Diagnostics are tests performed on samples taken from the human body, such as blood, urine, or tissue, to detect diseases, conditions, or infections.
- IMPACT.wf function: The IMPACT.wf system receives and displays alarm information and physiological data (like heart rate, ECG waveform, etc.) that has already been acquired and processed by other patient monitoring devices. It does not perform any tests on biological samples.
- Intended Use: The intended use clearly states it's for "secondary annunciation and display of selected alarm conditions at remote locations." It's a communication and display system, not a diagnostic test.
- Device Description: The description explicitly states, "The IMPACT.wf Server does not acquire physiological signals from a patient nor does it process the physiological data received from the patient monitors to determine patient status." This further confirms it's not performing diagnostic functions.
Therefore, the IMPACT.wf is a patient monitoring accessory or communication system, not an In Vitro Diagnostic device.
N/A
Intended Use / Indications for Use
The IMPACT.wf Mobile Waveform Receiving System is intended for the secondary annunciation and display of selected alarm conditions at remote locations throughout a defined area of coverage. The device is intended for use within the hospital/facility environment. The intended patient population is the same as the device generating the information used by the IMPACT.wf. The IMPACT.wf is not intended to replace primary monitoring via the central station, telemetry system, or patient bedside monitor.
Product codes
74 MSX
Device Description
The IMPACT.wf provides a secondary means for displaying and annunciating patient monitoring system alarm conditions at remote locations throughout a defined area of coverage in a hospital. The IMPACT.wf is not intended to replace the primary monitoring via the central station, patient bedside monitor, or telemetry system.
The IMPACT.wf consists of the following basic components: the IMPACT.wf Server (PC platform); Micro Serial Server; Transmitter; and Receiver(s) (Pagers). Optional components include Workstation(s).
The IMPACT.wf Server observes the Unity™ network for alarm packets containing information about patient events that are generated by the patient monitors. When alarm packets are observed, it processes the information, and transmits the information to the caregiver worn receiver(s). Data provided includes name, bed, heart rate, arrhythmia call, an ECG waveform, and enabled monitored parameter numerics (i.e. ECG heart rate, SpO2, ST, arterial BP, NBP and ART disconnect).
The IMPACT.wf Server does not acquire physiological signals from a patient nor does it process the physiological data received from the patient monitors to determine patient status. These functions are reserved for the patient monitoring system.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Not Found
Indicated Patient Age Range
The intended patient population is the same as the device generating the information used by the IMPACT.wf.
Intended User / Care Setting
hospital/facility environment
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
The IMPACT.wf complies with the voluntary standards as detailed in Section 9 of this submission. The following quality assurance measures were applied to the development of the IMPACT.wf:
- Requirements specification review .
- . Software validation and hardware testing
- Safety testing .
- . Environmental testing
- Final validation .
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
The results of these measurements demonstrate that IMPACT.wf is as safe, as effective, and performs as well as the predicate device.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s)
Reference Device(s)
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 870.2300 Cardiac monitor (including cardiotachometer and rate alarm).
(a)
Identification. A cardiac monitor (including cardiotachometer and rate alarm) is a device used to measure the heart rate from an analog signal produced by an electrocardiograph, vectorcardiograph, or blood pressure monitor. This device may sound an alarm when the heart rate falls outside preset upper and lower limits.(b)
Classification. Class II (performance standards).
0
. . .
| 510(k) Summary of Safety and Effectiveness | |
|---|---|
| Date: | December 29, 1999 |
| Submitter: | GE Marquette Medical Systems, Inc. |
| 8200 West Tower Avenue | |
| Milwaukee, WI 53223 USA | |
| Contact Person: | Karen Webb |
| Sr. Regulatory Affairs Specialist | |
| GE Marquette Medical Systems, Inc. | |
| Phone: (414) 362-3329 | |
| Fax: (414) 362-2420 | |
| Device: | |
| Trade Name: | IMPACT.wf Mobile Waveform Receiving System |
| Common/Usual Name: | Pager |
| Classification Names: | System, Network and Communication, Physiological Monitor 74 MSX |
| Predicate Devices: | K971868 |
| Marquette IMPACT (Informing Mobile Personnel and Care Tracking Pager System | |
| Device Description: | The IMPACT.wf provides a secondary means for displaying and |
| annunciating patient monitoring system alarm conditions at remote | |
| locations throughout a defined area of coverage in a hospital. The | |
| IMPACT.wf is not intended to replace the primary monitoring via the | |
| central station, patient bedside monitor, or telemetry system. | |
| The IMPACT.wf consists of the following basic components: the | |
| IMPACT.wf Server (PC platform); Micro Serial Server; Transmitter; and | |
| Receiver(s) (Pagers). Optional components include Workstation(s). | |
| The IMPACT.wf Server observes the Unity™ network for alarm packets | |
| containing information about patient events that are generated by the | |
| patient monitors. When alarm packets are observed, it processes the | |
| information, and transmits the information to the caregiver worn | |
| receiver(s). Data provided includes name, bed, heart rate, arrhythmia | |
| call, an ECG waveform, and enabled monitored parameter numerics | |
| (i.e. ECG heart rate, SpO2, ST, arterial BP, NBP and ART disconnect). | |
| The IMPACT.wf Server does not acquire physiological signals from a | |
| patient nor does it process the physiological data received from the | |
| patient monitors to determine patient status. These functions are | |
| reserved for the patient monitoring system. |
5
1
Intended Use:
The IMPACT.wf Mobile Waveform Receiving System is intended for the secondary annunciation and display of selected alarm conditions at remote locations throughout a defined area of coverage. The device is intended for use within the hospital/facility environment. The intended patient population is the same as the device generating the information used by the IMPACT.wf. The IMPACT.wf is not intended to replace primary monitoring via the central station, telemetry system, or patient bedside monitor.
Technology:
The IMPACT.wf employs the same functional technology as the predicate device.
Test Summary:
The IMPACT.wf complies with the voluntary standards as detailed in Section 9 of this submission. The following quality assurance measures were applied to the development of the IMPACT.wf:
- Requirements specification review .
- . Software validation and hardware testing
- Safety testing .
- . Environmental testing
- Final validation .
Conclusion:
The results of these measurements demonstrate that IMPACT.wf is as safe, as effective, and performs as well as the predicate device.
2
Image /page/2/Picture/1 description: The image is a black and white logo for the U.S. Department of Health & Human Services. The logo features the department's emblem, which is a stylized representation of a human figure embracing a bird. The text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" is arranged in a circular pattern around the emblem.
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
MAR 2 8 2000
Ms. Karen Webb GE Marquette Medical Systems 8200 W. Tower Avenue Milwaukee, WI 53223
Re: K994430 IMPACT.wf Mobile Waveform Receiving System Requlatory Class: III (three) Product Code: 74 MSX December 29, 1999 Dated: December 30, 1999 Received:
Dear Ms. Webb:
We have reviewed your Section 510(k) notification of intent to market the device referenced above and we have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (Premarket Approval), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Requlations, Title 21, Parts 800 to 895. A substantially equivalent determination assumes compliance with the Current Good Manufacturing Practice requirements, as set forth in the Quality System Regulation (QS) for Medical Devices: General requlation (21 CFR Part 820) and that, through periodic QS inspections, the Food and Drug Administration (FDA) will verify such assumptions. Failure to comply with the GMP regulation may result in regulatory action. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please note: this response to your premarket notification submission does not affect any obligation you might have under sections 531 through 542 of the Act for devices under the Electronic Product Radiation Control provisions, or other Federal laws or regulations.
3
Page 2 - Ms. Karen Webb
This letter will allow you to begin marketing your device as described in your 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801 and additionally 809.10 for in vitro diagnostic devices), please contact the Office of Compliance at (301) 594-4648. Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers Assistance at its toll-free number (800) 638-2041 or (301) 443-6597, or at its internet address "http://www.fda.qov/cdrh/dsma/dsmamain.html".
Sincerely yours,
team H. Weintraub for,
James E. Dillard III Director Division of Cardiovascular, Respiratory, and Neurological Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
4
510(k) Number (if known):
Unknown; 510(k) filed on December 29, 1999
Device Name:
IMPACT.wf Mobile Waveform Receiving System
Indications For Use:
The IMPACT.wf Mobile Waveform Receiving System is intended for the secondary annunciation and display of selected alarm conditions at remote locations throughout a The device is intended for use within the hospital/facility defined area of coverage. environment. The intended patient population is the same as the device generating the information used by the IMPACT.wf. The IMPACT.wf is not intended to replace primary monitoring via the central station, telemetry system, or patient bedside monitor.
(PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
Prescription Use (Per 21 CFR 801.109)
OR
Over-The-Counter Use_
(Optional Format 1-2-96)
L. Au. Arch
(Division Sign-Off)
Division of Cardiovascular, Respiratory.
510(k) Numb